Cardioprotective effects of epigallocatechin-3-gallate against doxorubicin-induced cardiomyocyte injury

European Journal of Pharmacology

Volumn 652, Issue 1-3, 2011, Pages 82-88

  Zheng, Jin ^a,c   Lee, Hui Ching Michelle ^a   Bin Sattar, Mohamad Mukmin ^a   Huang, Yu ^b   Bian, Jin Song ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b Chinese University of Hong Kong   (Hong Kong)

^c XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Cardiomyopathy; Cardioprotective; Doxorubicin; EGCG; Reactive oxygen species

Indexed keywords

CAFFEINE; CALCIUM; DICHLORODIHYDROFLUORESCEIN DIACETATE; DOXORUBICIN; EPIGALLOCATECHIN GALLATE; ISOPRENALINE; REACTIVE OXYGEN METABOLITE;

AMPLITUDE MODULATION; ANIMAL CELL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM DEPLETION; CARDIOTOXICITY; CELL DAMAGE; CELL PROTECTION; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HEART PROTECTION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SARCOPLASMIC RETICULUM; SPECTROFLUOROMETRY;

ANIMALS; ANTIOXIDANTS; CATECHIN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; MALE; MYOCYTES, CARDIAC; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

EID: 78650914850     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.10.082     Document Type: Article

References (41)

1. M.A. Aon, S. Cortassa, and B. O'Rourke Mitochondrial oscillations in physiology and pathophysiology Adv. Exp. Med. Biol. 641 2008 98 117
2. M. Arai, K. Tomaru, T. Takizawa, K. Sekiguchi, T. Yokoyama, T. Suzuki, and R. Nagai Sarcoplasmic reticulum genes are selectively down-regulated in cardiomyopathy produced by doxorubicin in rabbits J. Mol. Cell. Cardiol. 30 1998 243 254
3. M. Arai, A. Yoguchi, T. Takizawa, T. Yokoyama, T. Kanda, M. Kurabayashi, and R. Nagai Mechanism of doxorubicin-induced inhibition of sarcoplasmic reticulum Ca2+-ATPase gene transcription Circ. Res. 86 2000 8 14
4. A. Bast, G.R. Haenen, A.M. Bruynzeel, and W.J. Van der Vijgh Protection by flavonoids against anthracycline cardiotoxicity: from chemistry to clinical trials Cardiovasc. Toxicol. 7 2007 154 159
5. M.E. Billingham, J.W. Mason, M.R. Bristow, and J.R. Daniels Anthracycline cardiomyopathy monitored by morphologic changes Cancer Treat. Rep. 62 1978 865 872
6. A. Boraso, and A.J. Williams Modification of the gating of the cardiac sarcoplasmic reticulum Ca2+-release channel by H2O2 and dithiothreitol Am. J. Physiol. 267 1994 H1010 H1016
7. P. Caroni, F. Villani, and E. Carafoli The cardiotoxic antibiotic doxorubicin inhibits the Na+/Ca2+ exchange of dog heart sarcolemmal vesicles FEBS Lett. 130 1981 184 186
8. E.H. Choi, H.J. Chang, J.Y. Cho, and H.S. Chun Cytoprotective effect of anthocyanins against doxorubicin-induced toxicity in H9c2 cardiomyocytes in relation to their antioxidant activities Food Chem. Toxicol. 45 2007 1873 1881
9. Y. Clement Can green tea do that? A literature review of the clinical evidence Prev. Med. 49 2009 83 87
10. J.H. Doroshow, G.Y. Locker, J. Baldinger, and C.E. Myers The effect of doxorubicin on hepatic and cardiac glutathione Res. Commun. Chem. Pathol. Pharmacol. 26 1979 285 295
11. J.H. Doroshow, G.Y. Locker, and C.E. Myers Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin J. Clin. Invest. 65 1980 128 135
12. Y.E. Earm, W.K. Ho, and I. So Effects of adriamycin on ionic currents in single cardiac myocytes of the rabbit J. Mol. Cell. Cardiol. 26 1994 163 172
13. A.W. Girotti Lipid hydroperoxide generation, turnover, and effector action in biological systems J. Lipid Res. 39 1998 1529 1542
14. Q. Guo, B. Zhao, S. Shen, J. Hou, J. Hu, and W. Xin ESR study on the structure-antioxidant activity relationship of tea catechins and their epimers Biochim. Biophys. Acta 1427 1999 13 23
15. A.E. Hagerman, R.T. Dean, and M.J. Davies Radical chemistry of epigallocatechin gallate and its relevance to protein damage Arch. Biochem. Biophys. 414 2003 115 120
16. L.F. Hu, T.T. Pan, K.L. Neo, Q.C. Yong, and J.S. Bian Cyclooxygenase-2 mediates the delayed cardioprotection induced by hydrogen sulfide preconditioning in isolated rat cardiomyocytes Pflugers Arch. 455 2008 971 978
17. L.F. Hu, M. Lu, Z.Y. Wu, P.T. Wong, and J.S. Bian Hydrogen sulfide inhibits rotenone-induced apoptosis via preservation of mitochondrial function Mol. Pharmacol. 75 2009 27 34
18. M. Kawakami, and E. Okabe Superoxide anion radical-triggered Ca2+ release from cardiac sarcoplasmic reticulum through ryanodine receptor Ca2+ channel Mol. Pharmacol. 53 1998 497 503
19. M. Khan, S. Varadharaj, J. Shobha, M. Naidu, N.L. Parinandi, V.K. Kutala, and P. Kuppusamy C-phycocyanin ameliorates doxorubicin-induced oxidative stress and apoptosis in adult rat cardiomyocytes J. Cardiovasc. Pharmacol. 47 2006 9 20
20. S.Y. Kim, S.J. Kim, B.J. Kim, S.Y. Rah, S.M. Chung, M.J. Im, and U.H. Kim Doxorubicin-induced reactive oxygen species generation and intracellular Ca2+ increase are reciprocally modulated in rat cardiomyocytes Exp. Mol. Med. 38 2006 535 545
21. T. Komiyama, T. Kikuchi, and Y. Sugiura Generation of hydroxyl radical by anticancer quinone drugs, carbazilquinone, mitomycin C, aclacinomycin A and adriamycin, in the presence of NADPH-cytochrome P-450 reductase Biochem. Pharmacol. 31 1982 3651 3656
22. D. Kumar, L.A. Kirshenbaum, T. Li, I. Danelisen, and P.K. Singal Apoptosis in adriamycin cardiomyopathy and its modulation by probucol Antioxid. Redox Signal. 3 2001 135 145
23. M. Lu, L.F. Hu, G. Hu, and J.S. Bian Hydrogen sulfide protects astrocytes against H(2)O(2)-induced neural injury via enhancing glutamate uptake Free Radic. Biol. Med. 45 2008 1705 1713
24. R.L. Momparler, M. Karon, S.E. Siegel, and F. Avila Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells Cancer Res. 36 1976 2891 2895
25. D.G. Nagle, D. Ferreira, and Y.D. Zhou Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives Phytochemistry 67 2006 1849 1855
26. T. Nakagawa, and T. Yokozawa Direct scavenging of nitric oxide and superoxide by green tea Food Chem. Toxicol. 40 2002 1745 1750
27. J. Nijmeh, A. Moldobaeva, and E.M. Wagner Role of ROS in ischemia-induced lung angiogenesis Am. J. Physiol. Lung Cell. Mol. Physiol. 299 2010 L535 L541
28. R.D. Olson, H.A. Gambliel, R.E. Vestal, S.E. Shadle, H.A. Charlier, and B.J. Cusack Doxorubicin cardiac dysfunction: effects on calcium regulatory proteins, sarcoplasmic reticulum, and triiodothyronine Cardiovasc. Toxicol. Appl. Pharmacol. 5 2005 269 283
29. I.Y. Park, E.J. Kim, H. Park, K. Fields, A.K. Dunker, and C. Kang Interaction between cardiac calsequestrin and drugs with known cardiotoxicity Mol. Pharmacol. 67 2005 97 104
30. K. Saeki, I. Obi, N. Ogiku, M. Shigekawa, T. Imagawa, and T. Matsumoto Doxorubicin directly binds to the cardiac-type ryanodine receptor Life Sci. 70 2002 2377 2389
31. K.J. Schimmel, D.J. Richel, R.B. van den Brink, and H.J. Guchelaar Cardiotoxicity of cytotoxic drugs Cancer Treat. Rev. 30 2004 181 191
32. P.K. Singal, and G.N. Pierce Adriamycin stimulates low-affinity Ca2+ binding and lipid peroxidation but depresses myocardial function Am. J. Physiol. 250 1986 H419 H425
33. P.K. Singal, C.M. Deally, and L.E. Weinberg Subcellular effects of adriamycin in the heart: a concise review J. Mol. Cell. Cardiol. 19 1987 817 828
34. P.K. Singal, T. Li, D. Kumar, I. Danelisen, and N. Iliskovic Adriamycin-induced heart failure: mechanism and modulation Mol. Cell. Biochem. 207 2000 77 86
35. F. Timolati, D. Ott, L. Pentassuglia, M.N. Giraud, J.C. Perriard, T.M. Suter, and C. Zuppinger Neuregulin-1 beta attenuates doxorubicin-induced alterations of excitation-contraction coupling and reduces oxidative stress in adult rat cardiomyocytes J. Mol. Cell. Cardiol. 41 2006 845 854
36. J. Tong, P.K. Ganguly, and P.K. Singal Myocardial adrenergic changes at two stages of heart failure due to adriamycin treatment in rats Am. J. Physiol. 260 1991 H909 H916
37. T.L. Vanden Hoek, L.B. Becker, Z. Shao, C. Li, and P.T. Schumacker Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes J. Biol. Chem. 273 1998 18092 18098
38. C. Ventura, H. Spurgeon, E.G. Lakatta, C. Guarnieri, and M.C. Capogrossi Kappa and delta opioid receptor stimulation affects cardiac myocyte function and Ca2+ release from an intracellular pool in myocytes and neurons Circ. Res. 70 1992 66 81
39. R. von Harsdorf, P.F. Li, and R. Dietz Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis Circulation 99 1999 2934 2941
40. S. Wang, S. Kotamraju, E. Konorev, S. Kalivendi, J. Joseph, and B. Kalyanaraman Activation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide Biochem. J. 367 2002 729 740
41. R.B. Weiss The anthracyclines: will we ever find a better doxorubicin? Semin. Oncol. 19 1992 670 686